Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Regulatory News

Date Source Headline
13th May 2019 2:00 pm RNS Price Monitoring Extension
2nd May 2019 7:00 am RNS Acquisition of Intellectual Property& JV Agreement
29th Apr 2019 2:06 pm RNS Second Price Monitoring Extn
29th Apr 2019 2:01 pm RNS Price Monitoring Extension
29th Apr 2019 11:07 am RNS Second Price Monitoring Extn
29th Apr 2019 11:01 am RNS Price Monitoring Extension
29th Apr 2019 10:55 am RNS Holding(s) in Company
26th Apr 2019 7:00 am RNS Subscription, Convertible Funds and Warrant Issue
15th Apr 2019 7:15 am EQS Hardman & Co Research: Valirx (VAL): VAL401 is going forward
26th Mar 2019 7:00 am RNS ValiSeek Update
21st Mar 2019 7:00 am RNS Update on VAL201 & VAL301 Development Progress
21st Feb 2019 11:22 am RNS Placing, Issue of Equity and Warrant
31st Jan 2019 7:00 am RNS New patent grant allowances for VAL301
11th Jan 2019 7:00 am RNS Publication of VAL401 peer-reviewed article
9th Jan 2019 10:41 am RNS ValiRx endorses the Government's new NHS strategy
3rd Jan 2019 7:00 am RNS Holding(s) in Company
18th Dec 2018 4:41 pm RNS Second Price Monitoring Extn
18th Dec 2018 4:36 pm RNS Price Monitoring Extension
18th Dec 2018 11:25 am RNS Issue of Equity / PDMR Shareholdings
18th Dec 2018 7:00 am RNS Update on VAL401 - Peer-review Acceptance
10th Dec 2018 7:00 am RNS Update on VAL201 Clinical Trial
5th Nov 2018 7:00 am RNS Re scientific and investor meetings
1st Nov 2018 7:15 am EQS Hardman & Co Research: ValiRx (VAL): VAL401 Phase II trial completed
24th Oct 2018 7:00 am RNS Align Research Initiates Coverage
17th Oct 2018 7:00 am RNS VAL201 in concluding stages of Phase I/II trial
15th Oct 2018 12:00 pm RNS VAL401 results shortly to be on ClinicalTrials.gov
25th Sep 2018 7:00 am RNS Half-year Report
14th Sep 2018 12:42 pm RNS Issue of Equity
6th Sep 2018 7:00 am RNS Update on Clinical Development
24th Jul 2018 12:17 pm RNS Result of General Meeting
17th Jul 2018 7:00 am RNS US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
6th Jul 2018 4:42 pm RNS Notice of GM
14th Jun 2018 7:00 am RNS VAL401 Update
24th May 2018 9:00 am RNS Price Monitoring Extension
11th May 2018 2:56 pm RNS Holding(s) in Company
8th May 2018 12:13 pm RNS Result of AGM
4th May 2018 4:40 pm RNS Second Price Monitoring Extn
4th May 2018 4:35 pm RNS Price Monitoring Extension
4th May 2018 4:01 pm RNS Placing and grant of warrants
26th Apr 2018 2:05 pm RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,809.74
Change53.53